These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33478183)

  • 41. Serum Fork-Head Box D3 (FOXD3) Expression Is Down-Regulated in and Associated with Diagnosis of Patients with Non-Small Cell Lung Cancer.
    Xu BN; Zhang L; Zhang DD; Song CY; Tian DL; Jiang WJ
    Med Sci Monit; 2018 Dec; 24():9504-9508. PubMed ID: 30596382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.
    Su XY; Wang WY; Li JN; Liao DY; Wu WL; Li GD
    Int J Clin Exp Pathol; 2015; 8(5):5354-62. PubMed ID: 26191237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pax8 expression in thymic epithelial neoplasms: an immunohistochemical analysis.
    Weissferdt A; Moran CA
    Am J Surg Pathol; 2011 Sep; 35(9):1305-10. PubMed ID: 21836478
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters.
    Park SY; Cho A; Bae MK; Lee CY; Kim DJ; Chung KY
    Clin Nucl Med; 2016 Jan; 41(1):15-20. PubMed ID: 26545017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors affecting the preoperative diagnosis of anterior mediastinal cysts.
    Gochi F; Omasa M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Sonobe M; Date H
    Gen Thorac Cardiovasc Surg; 2015 Jun; 63(6):349-53. PubMed ID: 25666659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.
    Pan CC; Chen PC; Wang LS; Lee JY; Chiang H
    Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
    Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
    Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thymoma and thymic carcinoma associated with multilocular thymic cyst: a clinicopathologic analysis of 18 cases.
    Shen X; Jin Y; Shen L; Sun Y; Chen H; Li Y
    Diagn Pathol; 2018 Jun; 13(1):41. PubMed ID: 29945642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alteration in gene expression profiles of thymoma: Genetic differences and potential novel targets.
    Meng FJ; Wang S; Zhang J; Yan YJ; Wang CY; Yang CR; Guan ZY; Wang CL
    Thorac Cancer; 2019 May; 10(5):1129-1135. PubMed ID: 30932350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms.
    Nakajima J; Takamoto S; Oka T; Tanaka M; Takeuchi E; Murakawa T
    Eur J Cardiothorac Surg; 2000 Sep; 18(3):287-92. PubMed ID: 10973537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Whole-Tumor Histogram Analysis of Apparent Diffusion Coefficient Maps for Differentiating Thymic Carcinoma from Lymphoma.
    Zhang W; Zhou Y; Xu XQ; Kong LY; Xu H; Yu TF; Shi HB; Feng Q
    Korean J Radiol; 2018; 19(2):358-365. PubMed ID: 29520195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Correlation between clinical aggressiveness of thymic epithelial tumors and expression of tumor suppressor gene products (p53, p27)].
    Fukiwake N; Kase S; Yamazaki K; Yano T; Sugimachi K
    Fukuoka Igaku Zasshi; 1999 Aug; 90(8):339-41. PubMed ID: 10496046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic roles of MUC1 and GLUT1 in differentiating thymic carcinoma from type B3 thymoma.
    Du MJ; Shen Q; Yin H; Rao Q; Zhou MX
    Pathol Res Pract; 2016 Nov; 212(11):1048-1051. PubMed ID: 27688088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma.
    Katsuya Y; Fujita Y; Horinouchi H; Ohe Y; Watanabe S; Tsuta K
    Lung Cancer; 2015 May; 88(2):154-9. PubMed ID: 25799277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
    Chan JK; Tsang WY; Seneviratne S; Pau MY
    Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Thymic carcinomas].
    Ströbel P; Weis CA; Marx A
    Pathologe; 2016 Sep; 37(5):425-33. PubMed ID: 27538748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
    Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
    Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel prognostic signature of seven genes for the prediction in patients with thymoma.
    Li Q; Su YL; Shen WX
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):109-116. PubMed ID: 30328513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of DNA flow cytometry in thymomas and thymic carcinomas.
    Sauter ER; Sardi A; Hollier LH; Cooper ES; Bolton JS
    South Med J; 1990 Jun; 83(6):656-9. PubMed ID: 2356499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
    Fan W; Yang H; Xue H; Sun Y; Zhang J
    Int J Clin Exp Pathol; 2015; 8(5):5503-8. PubMed ID: 26191257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.